IBDEI1A1 ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,22620,1,4,0)
 ;;=4^276.0
 ;;^UTILITY(U,$J,358.3,22620,1,5,0)
 ;;=5^Hypernatremia
 ;;^UTILITY(U,$J,358.3,22620,2)
 ;;=^60144
 ;;^UTILITY(U,$J,358.3,22621,0)
 ;;=276.1^^125^1395^33
 ;;^UTILITY(U,$J,358.3,22621,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22621,1,4,0)
 ;;=4^276.1
 ;;^UTILITY(U,$J,358.3,22621,1,5,0)
 ;;=5^Hyponatremia
 ;;^UTILITY(U,$J,358.3,22621,2)
 ;;=Hyponatremia^60722
 ;;^UTILITY(U,$J,358.3,22622,0)
 ;;=275.3^^125^1395^27
 ;;^UTILITY(U,$J,358.3,22622,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22622,1,4,0)
 ;;=4^275.3
 ;;^UTILITY(U,$J,358.3,22622,1,5,0)
 ;;=5^Hyper Or Hypophosphatemia
 ;;^UTILITY(U,$J,358.3,22622,2)
 ;;=^93796
 ;;^UTILITY(U,$J,358.3,22623,0)
 ;;=250.40^^125^1395^16
 ;;^UTILITY(U,$J,358.3,22623,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22623,1,4,0)
 ;;=4^250.40
 ;;^UTILITY(U,$J,358.3,22623,1,5,0)
 ;;=5^DM type II with Nephropathy
 ;;^UTILITY(U,$J,358.3,22623,2)
 ;;=DM type II with Nephropathy^267837^583.81
 ;;^UTILITY(U,$J,358.3,22624,0)
 ;;=790.93^^125^1395^1
 ;;^UTILITY(U,$J,358.3,22624,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22624,1,4,0)
 ;;=4^790.93
 ;;^UTILITY(U,$J,358.3,22624,1,5,0)
 ;;=5^Abnormal PSA
 ;;^UTILITY(U,$J,358.3,22624,2)
 ;;=Abnormal PSA^295772
 ;;^UTILITY(U,$J,358.3,22625,0)
 ;;=627.3^^125^1395^3
 ;;^UTILITY(U,$J,358.3,22625,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22625,1,4,0)
 ;;=4^627.3
 ;;^UTILITY(U,$J,358.3,22625,1,5,0)
 ;;=5^Atrophic Vaginitis
 ;;^UTILITY(U,$J,358.3,22625,2)
 ;;=^270577
 ;;^UTILITY(U,$J,358.3,22626,0)
 ;;=607.1^^125^1395^6
 ;;^UTILITY(U,$J,358.3,22626,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22626,1,4,0)
 ;;=4^607.1
 ;;^UTILITY(U,$J,358.3,22626,1,5,0)
 ;;=5^Balanitis
 ;;^UTILITY(U,$J,358.3,22626,2)
 ;;=^12530
 ;;^UTILITY(U,$J,358.3,22627,0)
 ;;=596.0^^125^1395^7
 ;;^UTILITY(U,$J,358.3,22627,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22627,1,4,0)
 ;;=4^596.0
 ;;^UTILITY(U,$J,358.3,22627,1,5,0)
 ;;=5^Bladder Neck Obstruction
 ;;^UTILITY(U,$J,358.3,22627,2)
 ;;=^15144
 ;;^UTILITY(U,$J,358.3,22628,0)
 ;;=595.0^^125^1395^10
 ;;^UTILITY(U,$J,358.3,22628,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22628,1,4,0)
 ;;=4^595.0
 ;;^UTILITY(U,$J,358.3,22628,1,5,0)
 ;;=5^Cystitis, Acute
 ;;^UTILITY(U,$J,358.3,22628,2)
 ;;=^259104
 ;;^UTILITY(U,$J,358.3,22629,0)
 ;;=595.82^^125^1395^11
 ;;^UTILITY(U,$J,358.3,22629,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22629,1,4,0)
 ;;=4^595.82
 ;;^UTILITY(U,$J,358.3,22629,1,5,0)
 ;;=5^Cystitis, Radiation
 ;;^UTILITY(U,$J,358.3,22629,2)
 ;;=^270391
 ;;^UTILITY(U,$J,358.3,22630,0)
 ;;=596.59^^125^1395^17
 ;;^UTILITY(U,$J,358.3,22630,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22630,1,4,0)
 ;;=4^596.59
 ;;^UTILITY(U,$J,358.3,22630,1,5,0)
 ;;=5^Detrusor Muscle Insuff
 ;;^UTILITY(U,$J,358.3,22630,2)
 ;;=^270393
 ;;^UTILITY(U,$J,358.3,22631,0)
 ;;=788.1^^125^1395^18
 ;;^UTILITY(U,$J,358.3,22631,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22631,1,4,0)
 ;;=4^788.1
 ;;^UTILITY(U,$J,358.3,22631,1,5,0)
 ;;=5^Dysuria
 ;;^UTILITY(U,$J,358.3,22631,2)
 ;;=^37716
 ;;^UTILITY(U,$J,358.3,22632,0)
 ;;=604.90^^125^1395^41
 ;;^UTILITY(U,$J,358.3,22632,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22632,1,4,0)
 ;;=4^604.90
 ;;^UTILITY(U,$J,358.3,22632,1,5,0)
 ;;=5^Orchitis/Epididymit
 ;;^UTILITY(U,$J,358.3,22632,2)
 ;;=^86178
 ;;^UTILITY(U,$J,358.3,22633,0)
 ;;=607.84^^125^1395^34
 ;;^UTILITY(U,$J,358.3,22633,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22633,1,4,0)
 ;;=4^607.84
 ;;^UTILITY(U,$J,358.3,22633,1,5,0)
 ;;=5^Impotence, Organic Origin
 ;;^UTILITY(U,$J,358.3,22633,2)
 ;;=^270441
 ;;
 ;;$END ROU IBDEI1A1
